Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

High-resolution melting curve analysis of polymorphisms within CD58, CD226, HLA-G genes and association with multiple sclerosis susceptibility in a subset of Iranian population: a case-control study.

Ghavimi R, Alsahebfosoul F, Salehi R, Kazemi M, Etemadifar M, Zavaran Hosseini A.

Acta Neurol Belg. 2018 Aug 20. doi: 10.1007/s13760-018-0992-y. [Epub ahead of print]

PMID:
30128676
2.

HLA-G gene polymorphism and soluble HLA-G serum level in patients with multiple sclerosis.

Jahanbani-Ardakani H, Alsahebfosoul F, Etemadifar M, Salehi R, Eskandari N, Abtahi SH.

APMIS. 2018 Jun;126(6):538-539. doi: 10.1111/apm.12846. No abstract available.

PMID:
29924453
3.

The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.

Ben Fredj N, Sakly K, Bortolotti D, Aissi M, Frih-Ayed M, Rotola A, Caselli E, Cura F, Sakly N, Aouni M, Di Luca D, Rizzo R.

Immunol Lett. 2016 Dec;180:24-30. doi: 10.1016/j.imlet.2016.10.006. Epub 2016 Oct 19.

PMID:
27771469
4.

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.

Rodi M, Dimisianos N, de Lastic AL, Sakellaraki P, Deraos G, Matsoukas J, Papathanasopoulos P, Mouzaki A.

Int J Mol Sci. 2016 Aug 25;17(9). pii: E1398. doi: 10.3390/ijms17091398.

5.

Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.

Rizzo R, Pietrobon S, Mazzoni E, Bortolotti D, Martini F, Castellazzi M, Casetta I, Fainardi E, Di Luca D, Granieri E, Tognon M; Emilia-Romagna network for Multiple Sclerosis (ERMES) study group.

J Transl Med. 2016 Jul 22;14(1):216. doi: 10.1186/s12967-016-0981-y.

6.

Corrigendum to "An investigation into the association between HLA-G 14bp insertion/deletion polymorphism and multiple sclerosis susceptibility" [Journal of Neuroimmunology 290 (2016) 115-118].

Mohammadi N, Adib M, Alsahebfosoul F, Kazemi M, Etemadifar M.

J Neuroimmunol. 2016 Jun 15;295-296:164. doi: 10.1016/j.jneuroim.2016.03.001. Epub 2016 Mar 22. No abstract available.

PMID:
27235363
7.

The correlation of HLA-G with multiple sclerosis.

Zahednasab H, Karampoor S.

J Neuroimmunol. 2016 Feb 15;291:28. doi: 10.1016/j.jneuroim.2015.12.002. Epub 2015 Dec 7. No abstract available.

PMID:
26857491
8.

CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.

Pankratz S, Ruck T, Meuth SG, Wiendl H.

Hum Immunol. 2016 Sep;77(9):727-33. doi: 10.1016/j.humimm.2016.01.016. Epub 2016 Jan 27. Review.

PMID:
26826445
9.

Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.

Shalaby SM, Sabbah NA, Saber T, Abdel Hamid RA.

IUBMB Life. 2016 Feb;68(2):106-15. doi: 10.1002/iub.1469. Epub 2016 Jan 12. Review.

10.

An investigation into the association between HLA-G 14 bp insertion/deletion polymorphism and multiple sclerosis susceptibility.

Mohammadi N, Adib M, Alsahebfosoul F, Kazemi M, Etemadifar M.

J Neuroimmunol. 2016 Jan 15;290:115-8. doi: 10.1016/j.jneuroim.2015.11.019. Epub 2015 Nov 27.

PMID:
26711580
11.
12.

Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.

Alsahebfosoul F, Zavaran Hosseini A, Salehi R, Etemadifar M, Esmaeil N, Jamshidian A.

Iran J Allergy Asthma Immunol. 2015 Jun;14(3):298-305.

13.

Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis.

Fainardi E, Bortolotti D, Bolzani S, Castellazzi M, Tamborino C, Roversi G, Baldi E, Caniatti ML, Casetta I, Gentili V, Granieri E, Rizzo R; ERMES study group.

Mult Scler. 2016 Feb;22(2):245-9. doi: 10.1177/1352458515590647. Epub 2015 Jun 17.

PMID:
26084349
14.

Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.

Boppana S, Mindur JE, Balashov KE, Dhib-Jalbut S, Ito K.

J Neuroimmunol. 2013 Dec 15;265(1-2):68-74. doi: 10.1016/j.jneuroim.2013.10.007. Epub 2013 Oct 24.

PMID:
24200257
15.

Intrathecal soluble HLA-E correlates with disease activity in patients with multiple sclerosis and may cooperate with soluble HLA-G in the resolution of neuroinflammation.

Morandi F, Venturi C, Rizzo R, Castellazzi M, Baldi E, Caniatti ML, Tola MR, Granieri E, Fainardi E, Uccelli A, Pistoia V.

J Neuroimmune Pharmacol. 2013 Sep;8(4):944-55. doi: 10.1007/s11481-013-9459-3. Epub 2013 Apr 28.

PMID:
23625177
16.

Genome-wide pathway analysis of a genome-wide association study on multiple sclerosis.

Song GG, Choi SJ, Ji JD, Lee YH.

Mol Biol Rep. 2013 Mar;40(3):2557-64. doi: 10.1007/s11033-012-2341-1. Epub 2012 Dec 14.

PMID:
23238918
17.

Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.

Rizzo R, Bortolotti D, Fredj NB, Rotola A, Cura F, Castellazzi M, Tamborino C, Seraceni S, Baldi E, Melchiorri L, Tola MR, Granieri E, Baricordi OR, Fainardi E.

Hum Immunol. 2012 Nov;73(11):1140-6. doi: 10.1016/j.humimm.2012.08.005. Epub 2012 Aug 22.

PMID:
22922127
18.

Evaluation of soluble HLA-G as a biomarker for multiple sclerosis.

Waschbisch A, Sandbrink R, Hartung HP, Kappos L, Schwab S, Pohl C, Wiendl H.

Neurology. 2011 Aug 9;77(6):596-8. doi: 10.1212/WNL.0b013e318228c14d. Epub 2011 Jul 27. No abstract available.

PMID:
21795647
19.

Emerging topics and new perspectives on HLA-G.

Fainardi E, Castellazzi M, Stignani M, Morandi F, Sana G, Gonzalez R, Pistoia V, Baricordi OR, Sokal E, Peña J.

Cell Mol Life Sci. 2011 Feb;68(3):433-51. doi: 10.1007/s00018-010-0584-3. Epub 2010 Nov 16. Review.

PMID:
21080027
20.

Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population.

Wiśniewski A, Bilińska M, Klimczak A, Wagner M, Majorczyk E, Nowak I, Pokryszko-Dragan A, Kuśnierczyk P.

Int J Immunogenet. 2010 Aug;37(4):307-11. doi: 10.1111/j.1744-313X.2010.00926.x.

PMID:
20636826

Supplemental Content

Loading ...
Support Center